Literature DB >> 7607249

Induction of terminal enzymes for heme biosynthesis during differentiation of mouse erythroleukemia cells.

S Taketani1, T Yoshinaga, T Furukawa, H Kohno, R Tokunaga, K Nishimura, H Inokuchi.   

Abstract

To examine the induction of terminal enzymes of the heme-biosynthetic pathway during erythroid differentiation, mouse protoporphyrinogen oxidase (PPO) cDNA has been cloned. The deduced amino acid sequence derived from the nucleotide sequence revealed that mouse PPO consists of 477 amino acid residues, without the leader peptide, which is imported into mitochondria. Comparison of the amino terminus of the deduced amino acid sequence of mouse PPO cDNA with that of purified bovine PPO provided conclusive evidence for lack of the leader peptide in the former. The amino acid sequence has 86% and 28% identity with human PPO and Bacillus subtilis HemY, respectively. When mouse erythroleukemia (MEL) cells were induced with dimethylsulfoxide, PPO mRNA was induced within 12 h of treatment, and with further incubation, reached a plateau. mRNAs for coproporphyrinogen oxidase (CPO) and ferrochelatase (FEC) were induced within 12 h, and continued to increase with time up to 48 h. The activities of CPO and FEC markedly increased with time up to 72 h, while PPO activity increased 1.8-fold within 12 h and remained unchanged thereafter. Immunoblot analysis showed that levels of PPO, CPO and FEC paralleled their corresponding activities. The magnitude of PPO induction was less than that of CPO and FEC. Thus, induction of three terminal enzymes of the heme-biosynthetic pathway is an early event in MEL cell differentiation. The concomitant induction may play an important role in producing large amounts of heme during erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607249     DOI: 10.1111/j.1432-1033.1995.0760h.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Acylation stabilizes a protease-resistant conformation of protoporphyrinogen oxidase, the molecular target of diphenyl ether-type herbicides.

Authors:  S Arnould; M Takahashi; J M Camadro
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Authors:  Mira T Kassouf; Jim R Hughes; Stephen Taylor; Simon J McGowan; Shamit Soneji; Angela L Green; Paresh Vyas; Catherine Porcher
Journal:  Genome Res       Date:  2010-06-21       Impact factor: 9.043

Review 3.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

4.  Isolation and characterization of a mutant protoporphyrinogen oxidase gene from Chlamydomonas reinhardtii conferring resistance to porphyric herbicides.

Authors:  B L Randolph-Anderson; R Sato; A M Johnson; E H Harris; C R Hauser; K Oeda; F Ishige; S Nishio; N W Gillham; J E Boynton
Journal:  Plant Mol Biol       Date:  1998-11       Impact factor: 4.076

5.  The domain structure of protoporphyrinogen oxidase, the molecular target of diphenyl ether-type herbicides.

Authors:  S Arnould; J M Camadro
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 6.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

7.  Cloning and characterization of a plastidal and a mitochondrial isoform of tobacco protoporphyrinogen IX oxidase.

Authors:  I Lermontova; E Kruse; H P Mock; B Grimm
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

8.  Molecular basis of variegate porphyria: a missense mutation in the protoporphyrinogen oxidase gene.

Authors:  J Frank; H Lam; E Zaider; M Poh-Fitzpatrick; A M Christiano
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

9.  Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.

Authors:  A K Sinha; S Anand; B J Ortel; Y Chang; Z Mai; T Hasan; E V Maytin
Journal:  Br J Cancer       Date:  2006-07-25       Impact factor: 7.640

10.  Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes.

Authors:  B Ortel; N Chen; J Brissette; G P Dotto; E Maytin; T Hasan
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.